1887
Rapid communications Open Access
Like 0

Abstract

New Zealand, like other southern hemisphere countries with a temperate climate, has been in the winter period with seasonal influenza activity. New Zealand has also experienced a dramatic increase in the number of cases of pandemic influenza A(H1N1)v virus. Early reports from the northern hemisphere at the beginning of the pandemic showed that the virus was sensitive to the antiviral drug oseltamivir. In this study we report that pandemic influenza A(H1N1)v viruses currently circulating in New Zealand are sensitive to oseltamivir, but seasonal influenza A(H1N1) viruses – the co-circulating predominant seasonal strain, is resistant to oseltamivir.

Loading

Article metrics loading...

/content/10.2807/ese.14.30.19282-en
2009-07-30
2017-11-23
http://instance.metastore.ingenta.com/content/10.2807/ese.14.30.19282-en
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/14/30/art19282-en.htm?itemId=/content/10.2807/ese.14.30.19282-en&mimeType=html&fmt=ahah
Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error